Fund moves

Baxter International (BAX): Thompson Siegel & Walmsley LLC reduced its stake -125K shares

Thompson Siegel & Walmsley LLC reduced its stake in Baxter International, per its Q3 2024 13F.

1.89M
Shares reported · -125K vs prior quarter
1.1%
Disclosed portfolio weight
$71.6M
Reported value
Holdings as of
Sep 30, 2024
Filed
Nov 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Nov 18, 2024CongressDisclosed purchase of BAX — reported range $1,001 - $15,000
    2. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid Plus (FC), Product Code 1854087
    3. Feb 25, 2025FDARecall: Baxter Mobile column TruSystem 7500 U, Product Code 1730720
    4. Feb 25, 2025FDARecall: Baxter TruSystem 7500, Product Code 4091000
    5. Feb 25, 2025FDARecall: Baxter Stationary column TruSystem 7500, Product Code 1717020
    6. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid (MC), Product Code 1773204
    7. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid (SC), Product Code 1854086
    8. Feb 25, 2025FDARecall: Baxter Stationary column TruSystem 7500 U, Product Code 1730731
    9. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid MR IMRIS, Product Code 2067886
    10. Feb 25, 2025FDARecall: Baxter Operating table column TS7500 MOBIUS, Product Code 1704695
    11. Feb 25, 2025FDARecall: Progressa Bed Surfaces, intended to be used to treat or prevent pulmonary or other complications associated with immobility, Product Codes P7520A19, P7520A20S,…
    12. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid (FC), Product Code 1854085
    13. Feb 25, 2025FDARecall: Baxter TruSystem 7500 Hybrid Plus (SC), Product Code 1854088
    14. Feb 28, 2025FDAFDA drug approval: Epinephrine Bitartrate IN 0.9% Sodium Chloride
    15. Feb 28, 2025FDAFDA device clearance: Intravascular Extension Sets and Accessories
    16. Mar 3, 2025FDARecall: Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS
    View the official recordSEC Form 13F-HR

    How to read SEC Form 13F-HR

    Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

    Full guide: What is an SEC Form 13F?

    What else is on file for Baxter International

    For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.

    How this filing works

    Explore the data

    Common questions

    What does this filing report about Baxter International (BAX) stock?

    Thompson Siegel & Walmsley LLC reduced its stake in Baxter International, per its Q3 2024 13F. Now 1.89M shares, $71.6M reported value, 1.1% of disclosed portfolio.

    When did it happen, and when was it made public?

    Holdings as of: Sep 30, 2024. Filed: Nov 12, 2024.

    Is this a trade made on a known date?

    No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

    Where does this information come from?

    From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

    What else has been disclosed about Baxter International recently?

    For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BAX page.

    Does this mean BAX stock is a buy or a sell?

    No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

    Is OQRO free?

    Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

    Other disclosures at Baxter International

    Everything OQRO holds on this company is on its BAX page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data